Abstract
Cellular acetylation homeostasis is a kinetic balance precisely controlled by histone acetyl-transferase (HAT) and histone deacetylase (HDAC) activities. The loss of the counterbalancing function of basal HAT activity alters the precious HAT:HDAC balance towards enhanced histone deacetylation, resulting in a loss of acetylation homeostasis, which is closely associated with neuronal apoptosis. However, the critical HAT member whose activity loss contributes to neuronal apoptosis remains to be identified. In this study, we found that inactivation of GCN5 by either pharmacological inhibitors, such as CPTH2 and MB-3, or by inactivation with siRNAs leads to a typical apoptosis in cultured cerebellar granule neurons. Mechanistically, the BH3-only protein Bim is transcriptionally upregulated by activated Egr-1 and E2F1 and mediates apoptosis following GCN5 inhibition. Furthermore, in the activity withdrawal- or glutamate-evoked neuronal apoptosis models, GCN5 loses its activity, in contrast to Bim induction. Adenovirus-mediated overexpression of GCN5 suppresses Bim induction and apoptosis. Interestingly, the loss of GCN5 activity and the induction of Egr-1, E2F1 and Bim are involved in the early brain injury (EBI) following subarachnoid haemorrhage (SAH) in rats. HDAC inhibition not only significantly rescues Bim expression and apoptosis induced by either potassium deprivation or GCN5 inactivation but also ameliorates these events and EBI in SAH rats. Taken together, our results highlight a new mechanism by which the loss of GCN5 activity promotes neuronal apoptosis through the transcriptional upregulation of Bim, which is probably a critical event in triggering neuronal death when cellular acetylation homeostasis is impaired.
Similar content being viewed by others
Main
Subarachnoid hemorrhage (SAH) is a disastrous cerebrovascular disease, with a combined mortality and disability rate >50%.1 Accumulating evidences suggested that neuronal apoptosis is a critical pathological contributor to the SAH-induced early brain injury (EBI), which is considered to be the primary cause of a poor outcome for the patients and defined as the events occurring within the first 72 h after the SAH onset,2, 3, 4 but related molecular mechanisms are still not well understood.
Acetylation homeostasis refers to a steady acetylation status of histones and non-histone proteins, resulting from a kinetic balance between histone acetyl-transferase (HAT) and histone deacetylase (HDAC) activities.5 The homeostasis confers stability to the cellular homeostasis by coordinating gene expression and repression on both a temporal and spatial basis and therefore has a vital role in modulating cellular fate.6
Recently, it was found that the loss of acetylation homeostasis is closely associated with neuronal apoptosis and nervous diseases.7, 8 Once the balance becomes impaired, the HDAC:HAT ratio tilts in favour of HDAC activity in terms of availability and enzymatic functionality. Indeed, various HDAC inhibitors have been demonstrated to prevent neuronal apoptosis induced by oxidative stress9 or DNA damage.10 Furthermore, nervous diseases, including Alzheimer’s disease (AD), Parkinson’s disease, Huntington’s disease, ischaemia, haemorrhage, multiple sclerosis and Friedreich’s ataxia, were ameliorated with obvious decreases in apoptosis after administration of HDAC inhibitors.8, 11 However, decreasing HAT activity also results in a loss of acetylation; the critical HAT member whose loss of activity contributes to neuronal apoptosis remains to be identified.
General control non-derepressible 5 (GCN5) was the first enzyme identified to possess intrinsic HAT activity and link histone acetylation to transcriptional regulation.12 GCN5 exists as components of two large multisubunit complexes, which have global chromatin-modifying functions by acetylating histones genome wide or perform gene-specific regulation through specific loci.13 Meanwhile, these complexes also regulate multiple transcriptions through the deubiquitylation of H2B14 or suppression of p53-dependent apoptosis by deubiquitinating and stabilizing Sirt1.15 GCN5−/− mice die during embryogenesis and is featured with excessive apoptosis.16, 17 GCN5 depletion accelerates cerebellar and retinal degeneration in spinal cerebellar ataxia type 7 (SCA7) mice.18 These observations suggest that GCN5 has important roles in sustaining the homeostasis of acetylation, deubiquitylation and cellular survival.
In this study, we made an effort to understand the mechanism underlying the regulation of neuronal fate by GCN5. We found that inactivation of GCN5 results in E2F1- and Egr-1-dependent Bim induction and neuronal apoptosis. Furthermore, the loss of GCN5 activity and the transcriptional upregulation of E2F1, Egr-1 and Bim are involved in the SAH-induced EBI in rats. Interestingly, inhibition of HDACs significantly rescues Bim induction, apoptosis and EBI in SAH rats. Our results highlight that GCN5 loss-caused Bim induction is a critical event in triggering neuronal death when the cellular acetylation homeostasis is impaired.
Results
Inhibition of GCN5, but not p300 and Tip60, induces neuronal apoptosis
To determine a HAT member that is critical for neuronal survival, cerebellar granule neurons (CGNs) were treated with GCN5 inhibitors CPTH2 and MB-3,19, 20, 21 p300 inhibitor C646 or Tip60 inhibitor MG-149 at different doses for 24 h.22, 23, 24 The efficiency of the inhibitors was first evaluated by testing the changes in acetylation of H3K9, H3K27 or H4K12, which were evidenced to be catalysed by GCN5, p300 or Tip60, respectively.25, 26, 27 A dose-dependent inhibition of H3K9 acetylation by CPTH2 or MB-3 was observed, without affecting the acetylation of H3K27 or H4K12, or the expression of GCN5, although C646 or MG-149 dose-dependently suppresses the acetylation of H3K27 or H4K12, respectively, without decreasing H3K9 acetylation (Figure 1a). These results suggest that the corresponding inhibitor used shows high efficiency and specificity in blocking the activity of the three HATs.
Next, we assessed whether apoptosis occurs following treatment with the inhibitors by testing the typical apoptotic features, including nuclear pyknosis, DNA laddering and Caspase 3 activation.28 CGNs were induced to undergo apoptosis by potassium deprivation (5K treatment) as positive controls. Both CPTH2 and MB-3, but not C646 or MG-149, remarkably induced nuclear pyknosis and DNA laddering (Figures 1b and c, P<0.05). Furthermore, CPTH2 and MB-3 dose- and time course-dependently activated Caspase 3, 6 or 7 and increased nuclear pyknosis, but C646 or MG-149 had no such effects (Figures 1d–g, P<0.05, Supplementary Figures S1a and b).The results suggest that inhibition of GCN5, but not p300 or Tip60, leads to a typical apoptosis in CGNs.
As pharmacological inhibitors might have off-targeted effects, we then introduced small interference RNAs (siRNAs) to specifically knockdown GCN5. The efficiency of the knockdown of two GCN5 siRNA fragments was first confirmed by abolishing the endogenous GCN5 expression in rat C6 glioma cells (Figure 2a). Furthermore, the siGCN5 fragments can efficiently silence GCN5 expression in CGNs (Figures 2b, P<0.05). As expected, the knockdown of GCN5 induced an obvious increase in apoptosis (Figures 2c, P<0.05). These results indicated that loss of GCN5 activity substantially induces neuronal apoptosis.
Inhibition of GCN5 transcriptionally upregulates Bim
Previous work has demonstrated that Bim upregulation is critical for apoptotic occurrence in CGNs.29, 30, 31 We then explored whether Bim is involved in the loss of GCN5-induced apoptosis. Indeed, both CPTH2 and MB-3 dose- and time course-dependently induced Bim expression. Bim induction started at 8 h posttreatment, earlier than the Caspase 3 activation and the increase in nuclear pyknosis. The bim mRNA levels were also upregulated following GCN5 inhibition (Figures 3a–c). A pulse chase assay showed that the increased bim mRNA levels predominantly came from new transcription but not mRNA stabilization (Figures 3d, P<0.05). Furthermore, the bim promoter activity monitored by a bim-luciferase reporter was upregulated following CPTH2 treatment or GCN5 knockdown (Figures 3e and g, P<0.05). The results suggest that loss of GCN5 transcriptionally upregulates Bim.
Bim mediates apoptosis induced by inhibition of GCN5
As Bim induction is prior to the activation of Caspase 3, it is reasonable to suppose that the induced Bim contributes to GCN5 loss-caused apoptosis. However, a previous study demonstrated that the induced Bim is primarily sequestered by Bcl-2 family members Bcl-2, Bcl-XL and Mcl-1,32 which would neutralize its pro-apoptotic roles. We then determined whether GCN5 inhibition changes these three proteins or their association with Bim. Excitingly, CPTH2 treatment dose-dependently suppressed Bcl-2 and Mcl-1 expression but without affecting Bcl-XL expression. Furthermore, bcl-2 and mcl-1 mRNA levels downregulate following GCN5 inhibition (Figures 4a and b). The results support that GCN5 inhibition-mediated suppression on the two proteins might facilitate Bim to promote apoptosis. Indeed, the knockdown of Bim completely abrogated the apoptosis induced by CPTH2 as well as the silencing of GCN5 (Figures 4c–f, P<0.05). The results indicate that inhibition of GCN5 leads to Bim-dependent apoptosis.
GCN5 inhibition-activated Egr-1 and E2F1 contributes to Bim induction
To explore the mechanisms that are involved in Bim induction following GCN5 inhibition, we first examined whether CPTH2 treatment can repress the expression of miR-24, a microRNA which is known to negatively regulate Bim expression.33 Q-PCR results showed that miR-24 levels in the CPTH2 group are not significantly different from those in control (Figure 5a, 0.05<P>0.05), indicating that Bim induction following GCN5 inhibition is not through alteration of miR-24 expression.
Next, we attempted to identify the potential transcriptional factors that could be implicated in Bim upregulation, including E2F1, FOXO1/3a, Egr-1, p53 and NF-κB, which have been demonstrated to directly target the Bim gene.29, 30, 34, 35, 36 Interestingly, inhibition of both the Egr-1 transcriptional activity by mithramycin A and chromomycin A3 and the CDK activities by the pan-CDK inhibitors indirubin-3’-oxime and flavopiridol remarkably blocked the CPTH2-induced Bim expression (Figure 5b). Furthermore, administration of olomoucine, a specific inhibitor for CDK4/6, but not roscovitine, a specific inhibitor for CDK2/5, abrogated the Bim induction (Figure 5b), suggesting that CDK4/6 activation contributes to Bim regulation following GCN5 inhibition. However, inhibition of Forkhead activity by IGF, JNK/c-Jun activity by SP600125, p53 activity by pifithrin-alpha or NF-kB activity by JSH-23 do not rescue the CPTH2-evoked Bim expression (Figure 5b).
To further determine that Egr-1 and CDK4/6 activation contribute to the Bim induction, we tested whether Egr-1 and E2F1, a critical transcriptional factor downstream of CDK4/6,37 are activated following GCN5 inhibition. As shown in Figures 5c–e, both Egr-1 and E2F1 were induced in a time- and dose-dependent manner by CPTH2. Consistently, egr-1 and e2f1 mRNA levels were also upregulated. Chromatin immunoprecipitation (ChIP) assay showed that the induced E2F1 and Egr-1 bind to the region (−2554 to −2343 bp) of bim promoter (Figures 5f and g), distinct from the originally identified region (−221 to +106 bp) (for details, see Discussion section and Supplementary Figure S5). Furthermore, knockdown of E2F1 or Egr-1 expression by siRNAs effectively rescued CPTH2-caused Bim induction, as well as apoptosis (Figures 5h–j, P<0.05). Together, the results clearly indicate that the GCN5 inhibition-activated E2F1 and Egr-1 contributes to Bim induction.
Potassium deprivation or glutamate exposure causes a loss of GCN5 activity, in contrast to E2F1, Egr-1 and Bim induction
CGNs undergo a typical apoptosis following potassium deprivation or glutamate, and a transcriptional upregulation of Bim has been implicated in the processes.29, 38 We then asked whether the loss of GCN5 activity is involved in potassium deprivation- or glutamate-induced Bim upregulation and apoptosis. Greatly,CGNs treated with 25K or 5K for 4 h or glutamate (in 25K) for 8 h caused a dramatic reduction in the acetylation of H3K9, meaning that GCN5 activity decreases (Figures 6a and 1a). Contrary to this, Bim, as well as E2F1 and Egr-1, are robustly induced (Figures 6b and c). Furthermore, 5K or glutamate treatment also results in a reduction in acetylation of other histone lysine sites, including H2BK5, H3K14, H3K27 and H4K5, suggesting that a loss of global acetylation occurs.
As a further test, in vitro HAT activity assays showed that 5K treatment for 2 h causes a significant decrease in GCN5 activity by 35% compared with control 25K and, for 4 h, a greater decrease by 58% (P<0.05). Interestingly, GCN5 also loses its binding capacity to Bim promoter following potassium deprivation (Supplementary Figures S2a and b). Together, the results suggest that potassium deprivation leads to a substantial reduction in GCN5 activity, contrary to the E2F1, Egr-1 and Bim induction.
Overexpression of GCN5 suppresses Egr-1, E2F1 and Bim expression and apoptosis
As potassium deprivation or glutamate-evoked Bim induction and apoptosis are accompanied by a loss of GCN5 activity, we then assessed whether elevating GCN5 activity can rescue the processes by introducing adenovirus-mediated overexpression of GCN5 in CGNs. Ad-GCN5 or the control Ad-GFP showed a high infectious efficiency in neurons, up to >60% (Figure 7a). Indeed, overexpression of GCN5 not only greatly suppressed basal Bim expression in the 25K condition but also remarkably inhibits 5K or glutamate-induced E2F1, Egr-1 and Bim expression. Accordingly, overexpression of GCN5 significantly reduces Caspase 3 activity and the apoptotic rate in 25K, 5K or glutamate conditions (Figures 7b–f, P<0.05). The results suggest that GCN5 has important roles in negatively modulating Bim expression and neuronal apoptosis.
SAH results in a transcriptional upregulation of Bim, E2F1 and Egr-1 but a downregulation of Bcl-2 and a loss of GCN5 activity
Recently, neuronal apoptosis was found to be implicated in the EBI following SAH, featured with a robust Bim induction.39, 40, 41 We then asked whether the events above demonstrated in vitro are involved in SAH-caused Bim induction and apoptosis in rats, including a loss of GCN5 activity, a transcriptional upregulation of E2F1 and Egr-1 and a downregulation of Bcl-2 and Mcl-1.
At 24 h after SAH, the animals in the SAH group demonstrated severe neurobehavioral dysfunction and markedly increased brain water content in both the left and right hemispheres compared with the sham group (Figures 8b and c, P<0.05). By taking the same part of basal cortical brain tissue marked in Figure 8a for further tests, we found that the rate of TUNEL-positive cells in the SAH group was much higher than that in the sham group. Similarly, the rate of nuclear irregularity in SAH also significantly increased (Figure 8d and Supplementary Figure S3a, P<0.05). Furthermore, the active Caspase 3 mainly occurred in cells co-stained with NeuN in the SAH group but barely in the sham group (Figure 8e and Supplementary Figures S3b and c, P<0.05), suggesting that SAH leads to a typical neuronal apoptosis.
Accompanied with the apoptosis, Bim and Egr-1 expression remarkably increased in NeuN-positive neurons but not in GFAP-positive glia in the SAH group (Figures 8f, g and Supplementary Figure S3d, P<0.05). Furthermore, SAH caused a transcriptional upregulation of Bim, Egr-1 and E2F1 and a downregulation of Bcl-2 (Figures 8h, i, Supplementary Figures S3e and f, P<0.05) but without changing Mcl-1 expression (data not shown).
Next, we examined whether SAH treatment caused a change in GCN5 activity. As shown in Figure 9a, GCN5 was mainly expressed in NeuN-positive neurons. Interestingly, SAH caused a significant decrease in GCN5 expression but without affecting the gcn5 mRNA levels (Figure 9b, P<0.05). As a result, the acetylation of H3K9 and GCN5 HAT activity remarkably reduced in the SAH group (Figures 9c–e, P<0.05). Furthermore, SAH also caused a decrease in Ac-H3K14, Ac-H4K12 and Ac-H2BK5 but without affecting Ac-H3K27 (Figure 10c, P<0.05), suggesting that global acetylation homoestasis during SAH-induced EBI is impaired.
Together, SAH results in a loss of GCN5 activity, concomitant with a transcriptional upregulation of Egr-1, E2F1 and Bim but a downregulation of Bcl-2.
Inhibition of HDACs rescues Bim induction and apoptosis following GCN5 inhibition, potassium deprivation or SAH
As loss of acetylation often inclines to the function of HDACs, we then determined whether Bim upregulation and neuronal apoptosis can be rescued by inhibition of HDACs. Indeed, three pan-HDAC inhibitors, including TSA, SAHA and VPA, can remarkably suppress Bim expression, as well as Egr-1 and E2F1, induced by either exposure of CPTH2 or potassium deprivation in CGNs. Paralleling with these, the activity of Caspase 3 and 6 reduced accordingly (Figures 10a, c, Supplementary Figures S4a and b). Consistently, HDAC inhibition significantly decreased the apoptotic rates evoked by CPTH2 or potassium deprivation compared with the respective control (Figures 10b and d, P<0.05). The results suggest that inhibition of HDAC can effectively rescue Bim-dependent CGN apoptosis under loss of GCN5 activity.
Next, we determined whether inhibition of HDAC by SAHA can rescue SAH-induced upregulation of Egr-1, E2F1 and Bim and significantly ameliorate EBI. As shown in Figure 10e, administration of SAHA causes a remarkable increase in Ac-H3K27, suggesting that the activity of HDACs was efficiently blocked. In SAH rats, SAHA administration led to a marked decrease in the Egr-1, E2F1 and Bim, as well as their mRNA levels, compared with the vehicle injection, but an increase in Bcl-2 protein and mRNA (Figures 10e and f). Consistent with these changes, SAH-induced apoptosis was significantly alleviated by SAHA (Figures 10f–h, P<0.05). Consequently, administration of SAHA led to a substantial improvement in the neurological score (Figures 10i, P<0.05) and alleviated brain oedema in SAH rats compared with vehicle (Figure 10j, P<0.05). Together, inhibition of HDAC significantly rescues Bim induction and apoptosis following loss of GCN5 activity in vitro and in vivo.
Discussion
A fact has been highlighted that several neurodegenerative or brain injury conditions can be ameliorated by treatment with various HDAC inhibitors. Oxidative stress, reported to be closely associated with these diseases, fails to induce neuronal apoptosis when cells are treated with HDAC inhibitors.42 These strongly point towards a loss of neuronal acetylation homeostasis during neuronal apoptosis and HDAC members are implicated in the process. However, among the 18 HDAC members, the role for each individual HDAC in regulating neuronal survival or death remains quite different. For example, the activity of HDAC1, 4, 5 or 6 contributes to neuronal apoptosis,43, 44, 45, 46, 47 whereas HDAC2, 3, 7 or Sirt1 are known to promote neuronal survival.9, 38, 48, 49, 50 The current evidence cannot completely explain the antiapoptotic effects of HDACIs in neurons because a global inhibition of HDACs by the pan-HDACIs would result in compromised effects between pro-survival HDAC signals and pro-apoptotic ones. Therefore, the critical event of acetylation loss-coupled neuronal apoptosis needs further exploration.
Notably, loss of basal HAT activity alters the precious HAT:HDAC balance towards enhanced histone deacetylation, resulting in a loss of acetylation homeostasis. Thus the effect of a loss of HAT activity on neuronal apoptosis deserves attention. In fact, previous studies have investigated the functions of HAT members in modulating neuron fate, and yet increasing HAT activities are often associated with apoptosis. For example, enhancing p300 HAT activity by upregulating PKCδ expression promotes the apoptosis of dopaminergic neurons.51 Similarly, Tip60 HAT activity mediates APP-induced lethality and apoptosis in neurons in the AD model.52 Furthermore, CBP/p300 cooperating with NF-Y and FOXO3a triggers apoptosis in sympathetic neurons.53 CBP promotes apoptosis in normal CGNs but loss of CBP by Caspase 6 facilitates neuronal apoptosis following potassium deprivation,54 suggesting that CBP exhibits different roles in regulating neuronal fate in different conditions.
In this study, we found that inhibition of GCN5 by CPTH2, a synthesized molecule derived from thiazole in budding yeast,28 or by GCN5 siRNAs is sufficient to induce neuronal apoptosis. Whereas inhibition of p300/CBP or Tip60 by C646 and MG-149, two small molecules that specifically inhibit the HAT activity by docking into the Lys-CoA-binding pocket,55, 56 respectively, does not lead to an obvious apoptosis, suggesting that although selective regulation of acetylation of promoters results in differential control of gene transcription, whether a loss of HAT:HDAC balance is associated with neuronal death largely depends on whether the protein belongs to proapoptotic or antiapoptotic groups of proteins. Indeed, the critical evidence for the loss of GCN5-coupled neuronal apoptosis is the transcriptional upregulation of Bim, accompanied by a downregulation of Bcl-2 and Mcl-1. The reduction of Bcl-2 and Mcl-1 frees Bim proteins to activate Bax or Bak and subsequently increases the mitochondria permeability, facilitating Caspase-dependent apoptosis.32 These results strongly suggest that the loss of GCN5 activity is a critical event among the epigenetic changes that trigger neuronal apoptosis.
However, in our CHIP assays shown in Figure 5g, we found that the induced Egr-1 and E2F1 binds to the region spanning −2554 to −2344 bp of the bim promoter following GCN5 inhibition, which is distinct from the region (−221 to +106 bp) originally identified to be regulated by the two transcriptional factors.29, 34, 57 By using other primer pairs to amplify the adjacent parts of the region (−2554 to −2344 bp), we confirmed that Egr-1 binds to a large range spanning −3022 to −2233 bp (~789 bp), whereas E2F1 binds to a region spanning −2554 to −2233 bp (~321 bp). Interestingly, no E2F1 was detected binding to the region (−221 to +106 bp), consistent with the previous report,34 although the induced Egr-1 binding to the region was detectable following GCN5 inhibition but very faint compared with that to the region (−3022 to −2233 bp) (Supplementary Figures S5a and b). Bioinformatics analysis indicates that three putative Egr-1 response sites (named as Egr-1-like site-1, 2, 3), which have been implicated in Egr-1-mediated regulation of Bim or Noxa transcription,58, 59 locate at the Egr-1 binding region, and one putative E2F site (TTGGGGC, E2F-like site) exists in the ~321 bp region,60 suggesting that the range spanning −3022 to −2233 bp could be a new critical region regulated by GCN5, Egr-1 and E2F1.
In conclusion, we demonstrated here that GCN5 activity is essential for survival and the loss of GCN5 activity results in a typical apoptosis in matured neurons. Mechanistically, in normal homeostasis, GCN5 activity is implicated in transcriptionally repressing Egr-1, E2F1 and Bim but promoting Bcl-2, Mcl-1 expression to prevent Bax or Bak from permeabilizing the mitochondria for survival. In neurons wherein global acetylation is impaired following potassium deprivation, glutamate or SAH, the loss of GCN5 activity-evoked E2F1- and Egr-1-dependent transcriptional upregulation of Bim is a critical step in triggering apoptosis, the concomitant downregulation of Bcl-2 and Mcl-1 might facilitate the process.32 Promisingly, HDAC inhibitors can significantly rescue the loss of GCN5-caused Bim induction and apoptosis, and two FDA-approved drugs, VPA and SAHA, are in hand (a schematic diagram illustrating the possible mechanisms is shown in Figure 10k).
Materials and methods
Neuronal culture and potassium deprivation
Rat CGNs were prepared from 7–8-day old Sprague-Dawley rat pups (15–19 g) as described previously.28 Briefly, neurons were dissociated from freshly dissected cerebella by mechanical disruption in the presence of trypsin and DNase and then seeded at a density of 1.5 × 106 cells/ml in basal modified Eagle’s medium containing 10% foetal bovine serum and 25 mM KCl (25K+S). Cytosine arabinoside (10 μM) was added 24 h after seeding to limit the growth of non-neuronal cells. For potassium deprivation, experiments were performed as described previously.28 Briefly, cells cultured in vitro for 7 days (DIV7) in medium containing 25K+S were switched into serum-free medium containing 25 or 5 mM KCl (25K or 5K) in the presence or absence of the inhibitors CPTH2, MB-3, C646, MG-149, SAHA, VPA and TSA, indirubin-3’-oxime, flavopiridol, mithramycin A, chromomycin A3, olomoucine (200 μM), roscovitine, IGF, SP600125, pifithrin-alpha or JSH-23 (Sigma, Shanghai, China). Cells that did not receive inhibitors received DMSO as a control. The final concentration of DMSO was <0.2%. For glutamate exposure, neurons were switched into 25K+glutamate (100 μM). The glutamate stock solution is 1000 × 100 μM in 1 N HCl.
Western blotting (WB)
WB analysis was performed as described in detail previously.28, 61 For tissue analysis, rats were killed at 24 h after SAH induction, and the cortical samples were homogenized in RIPA buffer (Sangon, Shanghai, China) and centrifuged at 12 000 × g for 15 min at 4 °C. The supernatants were collected and protein concentrations were determined with a BCA Kit (Thermo Fisher Scientific, Rockford, IL, USA). Equal amounts (60 μg) of protein per sample were subjected to WB. The antibodies used include: GCN5 (CST, no. 3305), H2B (CST, no. 2722), H3 (CST, no. 9715), H4 (CST, no. 2592), Ac-H2BK5 (CST, no. 2574), Ac-H3K9 (CST, no. 9671), Ac-H3K14 (CST, no. 7627), Ac-H3K27 (CST, no. 4353), Ac-H4K12 (CST, no. 2591), Ac-H4K5 (CST, no. 8647), Caspase 3 (CST, no. 9662), Caspase 6 (CST, no. 9762), Bim (CST, no. 3305), E2F1 (CST, no. 3742), Egr-1 (CST, no. 4154), GAPDH (no. 2118) (Cell Signaling Technology; diluted at 1:1000), Flag, or tubulin (Sigma; both diluted at 1:10 000). The horseradish peroxidase-conjugated secondary antibodies are used (Jackson ImmunoRes, West Grove, PA, USA), and signals are visualized by using the ECL chemiluminescence system (Thermo Fisher Scientific, Rockford, IL, USA).
Adenovirus infection
The recombinant adenovirus plasmid AdEasy Flag GCN5 got from Addgene (plasmid no. 14106, Cambridge, MA, USA) was originally constructed by Dr Pere Puigserver’s laboratory.62 After digesting with PacI, the big fragments of constructs were transfected into 293A cells for packing and the positive colony efficiently expressing GCN5 was selected for further amplification and purification as described previously.28 Ad-GFP was amplified and purified as a control.
DIV5 CGNs were infected with Ad-GFP or Ad-GCN5 at a multiplicity of infection of 100 for 48 h and subjected to WB and reverse transcription-PCR (RT-PCR) for further analysis. Cells were stained with the DNA dye bisbenzimide (Hoechst 33258; 5 μg/ml) to determine the infectious efficiency of the two adenovirus by scoring the rate of GFP-positive neurons in all cells in the same visual field.
DNA fragmentation analysis (DNA ladder)
Cells were lysed in TE lysate buffer (0.2% Triton X-100, 50 mM Tris, 10 mM EDTA), and 500 μl supernatants were added with 110 μl 300 mM sodium acetate and 500 μl isopropyl alcohol for extraction of DNA at −20 °C overnight. The precipitated DNA was resolved in 20 μl 10 mM Tris (pH 8.5) containing RNAse A and 5 μl DNA was analysed using gel electrophoresis (2% agarose). Photos were taken in a Gel Documentation System (WD-9413B, LIUYI, Inc, Beijing, China).
ChIP assays
ChIP assays were performed using the Enzymatic ChIP Assay Kit (Cell Signaling Technology) according to the manual and as previously described.28 Two micrograms of rabbit E2F1 and Egr-1 antibody (Cell Signaling Technology) were used for immunoprecipitation (IP). Purified DNA was subjected to PCR amplification using the primers spanning the E2F1- and Egr-1-binding sites on the bim promoter (forward, 5′-TGCCACCAAAGATCTCTACC-3′; reverse, 5′-GCATTTCCTCACAGAGTTGG-3′.
Reverse transcription-PCR
Total RNA was extracted and isolated from CGNs or brain tissue using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA) as described previously.28 With the Primer Premier 5.0 software (PREMIER Biosoft, Palo Alto, CA, USA), we designed primers that were specific for bim (forward 5′-CTACCAGATCCCCACTTTTC-3′, reverse 5′-GCCCTCCTCGTGTAAGTCTC-3′); e2f1 (forward 5′-GACTGTGACTTTGGGGACT-3′, reverse 5′-TGTTCACCTTCATTCCC-3′); egr-1 (forward 5′-CGAGCGAACAACCCTACGAGC-3′, reverse 5′-GAGGCAGAGGAAGACGATGAAGC-3′); bcl-2 (forward 5′-GGGATGCCTTTGTGGAACTA-3′, reverse 5'-ATTTGACCATTTGCCTGAAT-3'); mcl-1 (forward 5'-GAAACAAAGAGGCTGGGATG-3', reverse 5'-GTAGTTGGTGGCTGGAGGTT-3'), gcn5 (forward 5’-CATCGGTGGGATTTGCTT-3', reverse 5'-GTACTCGTCGGCGTAGGTG-3'); and actin (forward 5′-CAACTGGGACGATATGGAGAAG-3′ and reverse 5′-TCTCCTTCTGCATCCTGTCAG-3′).
Quantitative real-time PCR and microRNA
Small RNA was extracted by RNAiso for Small RNA following the protocol from the producer (TAKARA, Dalian, China). The miRNA RT was conducted using the Hairpin-it microRNA and U6 snRNA Normalization RT-PCR Quantitation Kit (GeneParma, Shanghai, China). Optimized primers for amplifying miRNA-24 (miR-24) were used per the manufacturer’s protocols. The qPCR was performed in ABI 7300 Real-Time PCR System (Applied Biosystems, Thermo Fisher Scientific, Waltham, MA, USA) and relative miR-24 expression was calculated using the formula ratio=2−ΔΔCt.
Immunofluorescence
Immunocytochemistry and confocal imaging were performed as described previously.28, 61 For tissue analysis, the rats were subjected to perfusion–fixation 24 h after sham or SAH-induction surgery, and the frozen brain samples were cut into 20 μm sections. One slice from every 6 serial cuttings in each segment was selected, and altogether 4–6 slices were collected for immunofluorescence. The slices were blocked with 5% normal donkey serum in PBS containing 0.3% Triton X-100 for 1 h at room temperature prior to incubation with primary antibody overnight at 4 °C. Secondary antibodies (FITC or CY3, 1:200) were incubated for 1 h at room temperature. After nucleic staining with Hoechst 33258, photos were taken on confocal (ZEISS, LSM 880, Göttingen, Germany) or fluorescence-inverted microscope (IX-71, Olympus, Beijing, China). Rabbit polyclonal antibody against GCN5, Bim, Egr1, active Caspase 3, mouse monoclonal antibody against β-galactosidase (β-Gal) (Cell Signaling Technology) and monoclonal antibody against NeurN (Millipore, Beijing, China) were used at a dilution 1:400, 1:100, 1:800, 1:100, 1:400 and 1:1000, respectively.
RNA interference
Two GCN5 siRNAs, siGCN5a 5′-UGUUCGAGCUC UCAAAGAU-3′ and siGCN5b 5′-GCACCCACCUGAUGAAUCA-3′, and two Bim siRNAs, siBima 5′-CAACCAUUAUCUCAGUGCA-3′ and siBimb 5′-GACAGAGAAGGUGGACAAUUG-3′, non-sense control (NC) 5′-UUCUCCGAACGUGUCACGUTT-3′, the siEgr-1 5′-GGACUUAAAGGCUCUUAAU-3′ and shE2F1 targeting 5′-GCATTAGAGATCTCTTTGA-3′ were used. To detect the interference efficiency, these siRNAs and non-sense control siRNAs (NC) were transfected into rat C6 glioma cells by RNAiMax (Invitrogen) according to the manufacturer’ s protocol. Forty-eight hours after transfection, cell lysates were harvested and processed for WB to detect the expression of these proteins.
In CGNs, DIV5 CGNs were transfected with NC and the siRNAs, together with pCMV-β-Gal by the calcium phosphate co-precipitation method.28 Forty-eight hours after transfection, cells were subjected to immunofluorescence and β-Gal was stained to mark the transfected cells. To determine the interference efficiency of the siRNAs, we referred to a method published by Cargnin et al.63 to quantify the rate of GCN5- or Bim-stained of all β-Gal-stained neurons. Briefly, images were acquired at × 20 magnification on confocal microscope using the same exposures. More than 100 cells transfected with siRNA or NC were taken. Each image was converted to 8 bit using the ImageJ software (NIH, Bethesda, MD, USA), and red channel (GCN5 or Bim staining) was adjusted to a 30–255 pixel threshold for counting GCN5- or Bim-stained of Gal-stained neurons.
For assessing the apoptosis rate affected by the siRNAs, EGFP was used to mark the transfected cells. After treatment, neurons were stained with Hoechst 33258 (5 μg/ml), and apoptotic rate was determined by scoring the percentage of GFP-positive neuron population with pyknotic nuclei. Unbiased counting cells (~600 for each group) were scored blindly without knowledge of their previous treatment.
Dual-luciferase reporter assays
The bim-luciferase (Luc) reporter, containing a 5.2 kb DNA fragment, was described previously.29, 30 For the dual-luciferase reporter assays, cells were transfected with 1 μg of a luciferase reporter plasmid and 200 ng of the pRL–CMV Renilla luciferase reporter plasmid (Promega, Beijing, China). To test the effect of CPTH2 on the reporter, neurons were kept in conditioned media for 12 h after transfection and then transferred to serum-free media 25K containing CPTH2 (50 μM) for 24 h. To observe the effect of siGCN5s on the reporter, neurons were kept in conditioned media for 48 h after transfection. Firefly luciferase activity was normalized to Renilla luciferase activity as reported previously.37
IP and HAT activity assays
IP assays were performed as described previously.64 The lysed CGNs after 25K or 5K treatment or the homogenized sham or SAH brain samples were immunoprecipitated with 2 μg GCN5 antibody or normal IgG and incubated with 30 μl agarose hydrazide beads with protein A plus G (Merck Millipore, Beijing, China). A small part of immunocomplexes was subjected to WB analysis to test the efficiency of IP first, and the left was subjected to HAT activity assays by using the HAT Activity Assay Kit according to the manual (Sigma). Briefly, for each assay, water was added to the EP tube containing the left immunocomplexes to a final volume of 40 μl and then 68 μl assay mix was added containing: 2 × HAT Assay Buffer 50 μl, HAT Substrate I 5 μl, HAT Substrate II (mixing before use) and 5 μl NADH Generating Enzyme 8 μl. This was mixed by gently pipetting up and down and starting the reaction by incubating the tubes at 37 °C for 3 h. After centrifuging at 5000 r.p.m. for 2 min, the supernatant (100 μl) was transferred to 96-well plate and sample was read in a spectrophotometer (Tecan Infinite, Männedorf, Switzerland) at 440 nm. HAT activity was expressed as the mean of O.D. values from at least three independent samples.
SAH animal model
All experimental procedures were conducted under the guideline of Institutional Animal Care and Use Committee of Guangzhou Medical University. Rats had free access to food and water in a room with temperature maintained at 27 °C. Adult Sprague-Dawley rats (230–270 g) were purchased from the Animal Center of Sun Yat-sen University (Guangzhou, China). SAH model was induced by endovascular perforation method as previously described.61 Rats were anaesthetized with 10% chloral hydrate (0.35 ml/100 g, i.p.) and were positioned prone in a stereotactic frame (RWD Life Science Co., Ltd, Shenzhen, China). The left external and internal carotid arteries were exposed and a 3.0 monofilament nylon suture was inserted into the left internal carotid artery through the external carotid artery to perforate bifurcation of the anterior and middle cerebral arteries. Sham-operated rats underwent identical procedures except the perforation.
Drug administration
Drug administration was performed as previously described.61 SAHA (Selleck Chemicals, Shanghai, China) was diluted in vehicle: sterile saline (11.25 μl), PEG400 (11.25 μl), and DMSO (2.5 μl) at concentration of 5 mmol/l. The diluted SAHA (100 μl/kg) or vehicle (100 μl/kg) was administered into the right lateral ventricle 24 h before SAH was induced with the following coordinates relative to bregma: 1.5 mm posterior; 1.0 mm right lateral; 3.7 mm below the horizontal plane of bregma. The needle of a 50 μl Hamilton syringe (RWD Life Science Co., Ltd) was inserted through a burr hole perforated on the skull. Automatically infused at a rate of 2 μl/min and the needle was removed 5 min after completing an infusion.
Experiment design and other methods
The detailed experiment designs and other methods used in this paper are listed in the Supplementary Data—Materials and Methods. The other methods, including measurement of brain water content, histone extraction from brain tissues, clinical evaluation, perfusion-fixation, TUNEL, slice preparation and cell counting, relative density analysis for the results of WB or RT-PCR, were performed as described previously.41, 61, 65
Statistical analysis
The statistical software SPSS version 18.0 was used for statistical analysis (IBM Co., Armonk, NY, USA). Data were determined to be normally distributed before analysis. Student’s two-tailed t-test was used for comparison between two different groups and ANOVA analysis was used with Fisher’s LSD multiple-comparison test for multiple comparisons. All P-values <0.05 were considered statistically significant.
References
Chen S, Feng H, Sherchan P, Klebe D, Zhao G, Sun X et al. Controversies and evolving new mechanisms in subarachnoid hemorrhage. Prog Neurobiol 2014; 115: 64–91.
Sehba FA, Hou J, Pluta RM, Zhang JH . The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol 2012; 97: 14–37.
Hasegawa Y, Suzuki H, Sozen T, Altay O, Zhang JH . Apoptotic mechanisms for neuronal cells in early brain injury after subarachnoid hemorrhage. Acta Neurochir Suppl 2011; 110: 43–48.
Cahill J, Calvert JW, Zhang JH . Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2006; 26: 1341–1353.
Scott I . Regulation of cellular homoeostasis by reversible lysine acetylation. Essays Biochem 2012; 52: 13–22.
Park JM, Jo SH, Kim MY, Kim TH, Ahn YH . Role of transcription factor acetylation in the regulation of metabolic homeostasis. Protein Cell 2015; 6: 804–813.
Fessler EB, Chibane FL, Wang Z, Chuang DM . Potential roles of HDAC inhibitors in mitigating ischemia-induced brain damage and facilitating endogenous regeneration and recovery. Curr Pharm Des 2013; 19: 5105–5120.
Saha RN, Pahan K . HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ 2006; 13: 539–550.
Peng S, Zhao S, Yan F, Cheng J, Huang L, Chen H et al. HDAC2 selectively regulates FOXO3a-mediated gene transcription during oxidative stress-induced neuronal cell death. J Neurosci 2015; 35: 1250–1259.
Brochier C, Dennis G, Rivieccio MA, McLaughlin K, Coppola G, Ratan RR et al. Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons. J Neurosci 2013; 33: 8621–8632.
Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT . Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci 2009; 32: 591–601.
Nagy Z, Tora L . Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. Oncogene 2007; 26: 5341–5357.
Rodriguez-Navarro S . Insights into SAGA function during gene expression. EMBO Rep 2009; 10: 843–850.
Morgan MT, Haj-Yahya M, Ringel AE, Bandi P, Brik A, Wolberger C . Structural basis for histone H2B deubiquitination by the SAGA DUB module. Science 2016; 351: 725–728.
Lin Z, Yang H, Kong Q, Li J, Lee SM, Gao B et al. USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development. Mol Cell 2012; 46: 484–494.
Bu P, Evrard YA, Lozano G, Dent SY . Loss of Gcn5 acetyltransferase activity leads to neural tube closure defects and exencephaly in mouse embryos. Mol Cell Biol 2007; 27: 3405–3416.
Xu W, Edmondson DG, Evrard YA, Wakamiya M, Behringer RR, Roth SY . Loss of Gcn5l2 leads to increased apoptosis and mesodermal defects during mouse development. Nat Genet 2000; 26: 229–232.
Atanassov BS, Evrard YA, Multani AS, Zhang Z, Tora L, Devys D et al. Gcn5 and SAGA regulate shelterin protein turnover and telomere maintenance. Mol Cell 2009; 35: 352–364.
Chimenti F, Bizzarri B, Maccioni E, Secci D, Bolasco A, Chimenti P et al. A novel histone acetyltransferase inhibitor modulating Gcn5 network: cyclopentylidene-[4-(4'-chlorophenyl)thiazol-2-yl)hydrazone. J Med Chem 2009; 52: 530–536.
Shibuya M, Hatano M, Kawamura K . Interactive histone acetylation and methylation in regulating transdifferentiation-related genes during tunicate budding and regeneration. Dev Dyn 2015; 244: 10–20.
Holmlund T, Lindberg MJ, Grander D, Wallberg AE . GCN5 acetylates and regulates the stability of the oncoprotein E2A-PBX1 in acute lymphoblastic leukemia. Leukemia 2013; 27: 578–585.
Marek R, Coelho CM, Sullivan RK, Baker-Andresen D, Li X, Ratnu V et al. Paradoxical enhancement of fear extinction memory and synaptic plasticity by inhibition of the histone acetyltransferase p300. J Neurosci 2011; 31: 7486–7491.
Formisano L, Guida N, Valsecchi V, Cantile M, Cuomo O, Vinciguerra A et al. Sp3/REST/HDAC1/HDAC2 complex represses and Sp1/HIF-1/p300 complex activates ncx1 gene transcription, in brain ischemia and in ischemic brain preconditioning, by epigenetic mechanism. J Neurosci 2015; 35: 7332–7348.
Cregan S, McDonagh L, Gao Y, Barr MP, O'Byrne KJ, Finn SP et al. KAT5 (Tip60) is a potential therapeutic target in malignant pleural mesothelioma. Int J Oncol 2016; 48: 1290–1296.
Lin W, Srajer G, Evrard YA, Phan HM, Furuta Y, Dent SY . Developmental potential of Gcn5(-/-) embryonic stem cells in vivo and in vitro. Dev Dyn 2007; 236: 1547–1557.
Jin Q, Yu LR, Wang L, Zhang Z, Kasper LH, Lee JE et al. Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation. EMBO J 2011; 30: 249–262.
Grezy A, Chevillard-Briet M, Trouche D, Escaffit F . Control of genetic stability by a new heterochromatin compaction pathway involving the Tip60 histone acetyltransferase. Mol Biol Cell 2016; 27: 599–607.
Yuan Z, Gong S, Luo J, Zheng Z, Song B, Ma S et al. Opposing roles for ATF2 and c-Fos in c-Jun-mediated neuronal apoptosis. Mol Cell Biol 2009; 29: 2431–2442.
Xie B, Wang C, Zheng Z, Song B, Ma C, Thiel G et al. Egr-1 transactivates Bim gene expression to promote neuronal apoptosis. J Neurosci 2011; 31: 5032–5044.
Gilley J, Coffer PJ, Ham J . FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 2003; 162: 613–622.
Ren D, Tu HC, Kim H, Wang GX, Bean GR, Takeuchi O et al. BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program. Science 2010; 330: 1390–1393.
Chen S, Dai Y, Pei XY, Grant S . Bim upregulation by histone deacetylase inhibitors mediates interactions with the Bcl-2 antagonist ABT-737: evidence for distinct roles for Bcl-2, Bcl-xL, and Mcl-1. Mol Cell Biol 2009; 29: 6149–6169.
Liu R, Zhang H, Wang X, Zhou L, Li H, Deng T et al. The miR-24-Bim pathway promotes tumor growth and angiogenesis in pancreatic carcinoma. Oncotarget 2015; 6: 43831–43842.
Biswas SC, Liu DX, Greene LA . Bim is a direct target of a neuronal E2F-dependent apoptotic pathway. J Neurosci 2005; 25: 8349–8358.
Rahimi A, Lee YY, Abdella H, Doerflinger M, Gangoda L, Srivastava R et al. Role of p53 in cAMP/PKA pathway mediated apoptosis. Apoptosis 2013; 18: 1492–1499.
Lanzillotta A, Sarnico I, Ingrassia R, Boroni F, Branca C, Benarese M et al. The acetylation of RelA in Lys310 dictates the NF-kappaB-dependent response in post-ischemic injury. Cell Death Dis 2010; 1: e96.
Osuga H, Osuga S, Wang F, Fetni R, Hogan MJ, Slack RS et al. Cyclin-dependent kinases as a therapeutic target for stroke. Proc Natl Acad Sci USA 2000; 97: 10254–10259.
Choi HK, Choi Y, Kang H, Lim EJ, Park SY, Lee HS et al. PINK1 positively regulates HDAC3 to suppress dopaminergic neuronal cell death. Hum Mol Genet 2015; 24: 1127–1141.
Yin C, Huang GF, Sun XC, Guo Z, Zhang JH . Tozasertib attenuates neuronal apoptosis via DLK/JIP3/MA2K7/JNK pathway in early brain injury after SAH in rats. Neuropharmacology 2016; 108: 316–323.
An JY, Zhou LL, Sun P, Pang HG, Li DD, Li Y et al. Role of the AMPK signaling pathway in early brain injury after subarachnoid hemorrhage in rats. Acta Neurochir (Wien) 2015; 157: 781–792.
Dong Y, Fan C, Hu W, Jiang S, Ma Z, Yan X et al. Melatonin attenuated early brain injury induced by subarachnoid hemorrhage via regulating NLRP3 inflammasome and apoptosis signaling. J Pineal Res 2016; 60: 253–262.
Gray SG, Dangond F . Rationale for the use of histone deacetylase inhibitors as a dual therapeutic modality in multiple sclerosis. Epigenetics 2006; 1: 67–75.
Lebrun-Julien F, Suter U . Combined HDAC1 and HDAC2 depletion promotes retinal ganglion cell survival after injury through reduction of p53 target gene expression. ASN Neuro 2015; 7: 1–17.
Bolger TA, Yao TP . Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death. J Neurosci 2005; 25: 9544–9553.
Wei JY, Lu QN, Li WM, He W . Intracellular translocation of histone deacetylase 5 regulates neuronal cell apoptosis. Brain Res 2015; 1604: 15–24.
Yuan L, Wang Z, Liu L, Jian X . Inhibiting histone deacetylase 6 partly protects cultured rat cortical neurons from oxygenglucose deprivationinduced necroptosis. Mol Med Rep 2015; 12: 2661–2667.
Rivieccio MA, Brochier C, Willis DE, Walker BA, D'Annibale MA, McLaughlin K et al. HDAC6 is a target for protection and regeneration following injury in the nervous system. Proc Natl Acad Sci USA 2009; 106: 19599–19604.
Bardai FH, Verma P, Smith C, Rawat V, Wang L, D'Mello SR . Disassociation of histone deacetylase-3 from normal huntingtin underlies mutant huntingtin neurotoxicity. J Neurosci 2013; 33: 11833–11838.
Ma C, D'Mello SR . Neuroprotection by histone deacetylase-7 (HDAC7) occurs by inhibition of c-jun expression through a deacetylase-independent mechanism. J Biol Chem 2011; 286: 4819–4828.
Araki T, Sasaki Y, Milbrandt J . Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 2004; 305: 1010–1013.
Jin H, Kanthasamy A, Ghosh A, Yang Y, Anantharam V, Kanthasamy AG . alpha-Synuclein negatively regulates protein kinase Cdelta expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity. J Neurosci 2011; 31: 2035–2051.
Pirooznia SK, Sarthi J, Johnson AA, Toth MS, Chiu K, Koduri S et al. Tip60 HAT activity mediates APP induced lethality and apoptotic cell death in the CNS of a Drosophila Alzheimer's disease model. PLoS One 2012; 7: e41776.
Hughes R, Kristiansen M, Lassot I, Desagher S, Mantovani R, Ham J . NF-Y is essential for expression of the proapoptotic bim gene in sympathetic neurons. Cell Death Differ 2011; 18: 937–947.
Rouaux C, Jokic N, Mbebi C, Boutillier S, Loeffler JP, Boutillier AL . Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J 2003; 22: 6537–6549.
Bowers EM, Yan G, Mukherjee C, Orry A, Wang L, Holbert MA et al. Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem Biol 2010; 17: 471–482.
Ghizzoni M, Wu J, Gao T, Haisma HJ, Dekker FJ, George Zheng Y . 6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site. Eur J Med Chem 2012; 47: 337–344.
Hershko T, Ginsberg D . Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. J Biol Chem 2004; 279: 8627–8634.
Wirth M, Stojanovic N, Christian J, Paul MC, Stauber RH, Schmid RM et al. MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib. Nucleic Acids Res 2014; 42: 10433–10447.
Thiel G, Schoch S, Petersohn D . Regulation of synapsin I gene expression by the zinc finger transcription factor zif268/egr-1. J Biol Chem 1994; 269: 15294–15301.
Gogada R, Yadav N, Liu J, Tang S, Zhang D, Schneider A et al. Bim, a proapoptotic protein, up-regulated via transcription factor E2F1-dependent mechanism, functions as a prosurvival molecule in cancer. J Biol Chem 2013; 288: 368–381.
Zhang XS, Wu Q, Wu LY, Ye ZN, Jiang TW, Li W et al. Sirtuin 1 activation protects against early brain injury after experimental subarachnoid hemorrhage in rats. Cell Death Dis 2016; 7: e2416.
Lerin C, Rodgers JT, Kalume DE, Kim SH, Pandey A, Puigserver P . GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha. Cell Metab 2006; 3: 429–438.
Cargnin F, Nechiporuk T, Mullendorff K, Stumpo DJ, Blackshear PJ, Ballas N et al. An RNA binding protein promotes axonal integrity in peripheral neurons by destabilizing REST. J Neurosci 2014; 34: 16650–16661.
He W, Wu Y, Tang X, Xia Y, He G, Min Z et al. HDAC inhibitors suppress c-Jun/Fra-1-mediated proliferation through transcriptionally downregulating MKK7 and Raf1 in neuroblastoma cells. Oncotarget 2016; 7: 6727–6747.
Shao A, Wang Z, Wu H, Dong X, Li Y, Tu S et al. Enhancement of autophagy by histone deacetylase inhibitor trichostatin a ameliorates neuronal apoptosis after subarachnoid hemorrhage in rats. Mol Neurobiol 2016; 53: 18–27.
Acknowledgements
We thank Dr. Mingtao Li (Sun Yat-sen University, China) and Dr Kaiyong Mei (Department of Pathology at our hospital) for the assistance in the constructs and H&E staining. This work was supported by the National Natural Science Foundation of China (Grant 31171021, 81671232), the foundation of Guangzhou Science Technology and Innovation Commission (Grant 201510010180), the Natural Science Foundation of Guangdong province (2015A030313475), and the foundation of Guangdong Science and Technology Department (2014A020212604).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Edited by M Agostini
Supplementary Information accompanies this paper on Cell Death and Disease website
Supplementary information
Rights and permissions
Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Wu, Y., Ma, S., Xia, Y. et al. Loss of GCN5 leads to increased neuronal apoptosis by upregulating E2F1- and Egr-1-dependent BH3-only protein Bim. Cell Death Dis 8, e2570 (2018). https://doi.org/10.1038/cddis.2016.465
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cddis.2016.465
This article is cited by
-
GCN5 mediates DNA-PKcs crotonylation for DNA double-strand break repair and determining cancer radiosensitivity
British Journal of Cancer (2024)
-
Targeting the E2F1/Rb/HDAC1 axis with the small molecule HR488B effectively inhibits colorectal cancer growth
Cell Death & Disease (2023)
-
MiR-106b-5p Attenuates Neuropathic Pain by Regulating the P2X4 Receptor in the Spinal Cord in Mice
Journal of Molecular Neuroscience (2022)
-
NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension
Cell Death & Disease (2017)